Efficacy and safety of Pegasys combined with adefovir in the treatment of chronic hepatitis B with HBeAg(+).
Phase of Trial: Phase III
Latest Information Update: 21 May 2012
At a glance
- Drugs Adefovir (Primary) ; Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 21 May 2012 Last checked against Chinese Clinical Trial Register record.
- 21 May 2012 Planned End Date changed from 1 Dec 2012 to 31 Dec 2012 as reported by Chinese Clinical Trial Register record.
- 16 Feb 2010 New trial record